Current issues surrounding the definition of trans-fatty acids: Implications for health, industry and food labels

British Journal of Nutrition

Volumn 110, Issue 8, 2013, Pages 1369-1383

  Wang, Ye ^a   Proctor, Spencer D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Conjugated linoleic acid; Ruminant trans fat; Trans fatty acids; Vaccenic acid

Indexed keywords

CONJUGATED LINOLEIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEOME; TRANS FATTY ACID; VACCENIC ACID; FAT INTAKE;

ANTICARCINOGENIC ACTIVITY; ANTICARDIOVASCULAR ACTIVITY; ANTIOBESITY ACTIVITY; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DRUG ACTIVITY; FAT CONTENT; FAT INTAKE; FAT MASS; FOOD PACKAGING; HUMAN; INSULIN SENSITIVITY; LIPID ABSORPTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ANIMAL; BOVIDS; CARDIOVASCULAR DISEASES; CLINICAL TRIAL (TOPIC); FOOD INDUSTRY; HEALTH CARE POLICY; HEALTH STATUS; NEOPLASMS; OBESITY; STANDARDS;

ANIMALS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIETARY FATS; DIETARY SUPPLEMENTS; FOOD INDUSTRY; FOOD LABELING; HEALTH STATUS; HUMANS; LINOLEIC ACIDS, CONJUGATED; NEOPLASMS; NUTRITION POLICY; OBESITY; RUMINANTS; TRANS FATTY ACIDS;

EID: 84892655675     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513001086     Document Type: Review

References (128)

1. Mozaffarian D, Aro A & Willett WC (2009) Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 63, Suppl. 2, S5-S21.
2. Brouwer IA, Wanders AJ & Katan MB (2010) Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans - a quantitative review. PloS one 5, e9434.
3. Voorrips LE, Brants HA, Kardinaal AF, et al. (2002) Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutr 76, 873-882.
4. Chavarro JE, Stampfer MJ, Campos H, et al. (2008) A prospective study of trans-fatty acid levels in blood and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 17, 95-101.
5. Vinikoor LC, Millikan RC, Satia JA, et al. (2010) Trans-fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II. Cancer Causes Control 21, 171-180.
6. Stachowska E (2008) Conjugated dienes of linoleic acid and tumorigenesis. Ann Acad Med Stetin 54, 122-125.
7. Kennedy A, Martinez K, Schmidt S, et al. (2010) Antiobesity mechanisms of action of conjugated linoleic acid. J Nutr Biochem 21, 171-179.
8. Reynolds CM & Roche HM (2010) Conjugated linoleic acid and inflammatory cell signalling. Prostaglandins Leukot Essent Fatty Acids 82, 199-204.
9. Gebauer SK, Chardigny JM, Jakobsen MU, et al. (2011) Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Adv Nutr 2, 332-354.
10. Bendsen NT, Christensen R, Bartels EM, et al. (2011) Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr 65, 773-783.
11. Brouwer IA, Wanders AJ & Katan MB (2013) Trans fatty acids and cardiovascular health-research completed? Eur J Clin Nutr (epublication ahead of print version 27 March 2013).
12. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2012) Statement on the safety of the "conjugated linoleic acid (CLA)-rich oils" Clarinol and Tonalin TG80 as Novel Food ingredients. EFSA J 10, 2700.
13. United States Food and Drug Administration (2007) GRAS notice inventory-GRN No.232 - conjugated linoleic acid isomers. http://www.accessdata.fda.gov/scripts/fcn/fcnDetailNavigation.cfm?rpt=grasListing&id=232
14. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010) Scientific opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers. EFSA J 8, 1794.
15. Riserus U, Arner P, Brismar K, et al. (2002) Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25, 1516-1521.
16. Riserus U, Basu S, Jovinge S, et al. (2002) Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 106, 1925-1929.
17. Riserus U, Vessby B, Arner P, et al. (2004) Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 47, 1016-1019.
18. Food Standards Australia New Zealand (FSANZ) (2009) Intake of trans fatty acids in New Zealand and Australia review report-2009 assessment. http://www.foodstandards.gov.au/-srcfiles/TFAs-Aus-NZ-Food%20-Supply.pdf
19. Palmquist DL, Lock AL, Shingfield KJ, et al. (2005) Biosynthesis of conjugated linoleic acid in ruminants and humans. Adv Food Nutr Res 50, 179-217.
20. McCrorie TA, Keaveney EM, Wallace JM, et al. (2011) Human health effects of conjugated linoleic acid from milk and supplements. Nutr Res Rev 24, 206-227.
21. Health Canada (2010) Conjugated Linoleic Acid. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/monograph/mono-cla-alc-eng.php
22. Tetens I (2010) Scientific Opinion on the safety of "conjugated linoleic acid (CLA)-rich oil" (Tonalin® TG 80) as a Novel Food ingredient. EFSA J 8, 1600.
23. Lock AL & Bauman DE (2004) Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids 39, 1197-1206.
24. Parodi PW (1999) Conjugated linoleic acid: an anticarcinogenic fatty acid present in milk fat. J Dairy Sci 82, 1339-1349.
25. Fritsche J & Steinhart H (1998) Amounts of conjugated linoleic acid (CLA) in German foods and evaluation of daily intake. Z Lebensm Unters Forsch 2065, 77-82.
26. Maurelli S, Blasi F, Cossignani L, et al. (2009) Enzymatic synthesis of structured triacylglycerols containing CLA isomers starting from sn-1,3-diacylglycerols. J Am Oil Chem Soc 86, 127-133.
27. Chardigny JM, Masson E, Sergiel JP, et al. (2003) The position of rumenic acid on triacylglycerols alters its bioavailability in rats. J Nutr 133, 4212-4214.
28. Valeille K & Martin JC (2004) Complete stereospecific determination of conjugated linoleic acids in triacylglycerol of milk-fat. Reprod Nutr Dev 44, 459-464.
29. Paterson LJ, Weselake RJ, Mir PS, et al. (2002) Positional distribution of CLA in TAG of lamb tissues. Lipids 37, 605-611.
30. Yurawecz MP, Hood JK, Mossoba MM, et al. (1995) Furan fatty acids determined as oxidation products of conjugated octadecadienoic acid. Lipids 30, 595-598.
31. Sugano M, Tsujita A, Yamasaki M, et al. (1997) Lymphatic recovery, tissue distribution, and metabolic effects of conjugated linoleic acid in rats. J Nutr Biochem 8, 38-43.
32. Martin JC, Sebedio JL, Caselli C, et al. (2000) Lymphatic delivery and in vitro pancreatic lipase hydrolysis of glycerol esters of conjugated linoleic acids in rats. J Nutr 130, 1108-1114.
33. Bracco U (1994) Effect of triglyceride structure on fat absorption. Am J Clin Nutr 60, 1002S-1009S.
34. Gervais R, Gagnon F, Kheadr EE, et al. (2009) Bioaccessibility of fatty acids from conjugated linoleic acid-enriched milk and milk emulsions studied in a dynamic in vitro gastrointestinal model. Int Dairy J 19, 574-581.
35. Engberink MF, Geleijnse JM, Wanders AJ, et al. (2012) The effect of conjugated linoleic acid, a natural trans fat from milk and meat, on human blood pressure: results from a randomized crossover feeding study. J Hum Hypertens 26, 127-132.
36. de Roos B, Wanders AJ, Wood S, et al. (2011) A high intake of industrial or ruminant trans fatty acids does not affect the plasma proteome in healthy men. Proteomics 11, 3928-3934.
37. Smit LA, Katan MB, Wanders AJ, et al. (2011) A high intake of trans fatty acids has little effect on markers of inflammation and oxidative stress in humans. J Nutr 141, 1673-1678.
38. Wanders AJ, Brouwer IA, Siebelink E, et al. (2010) Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects. PloS one 5, e9000.
39. Sluijs I, Plantinga Y, de Roos B, et al. (2010) Dietary supplementation with cis-9, trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Am J Clin Nutr 91, 175-183.
40. Asp ML, Collene AL, Norris LE, et al. (2011) Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: a randomized, doublemasked, crossover study. Clin Nutr 30, 443-449.
41. Joseph SV, Jacques H, Plourde M, et al. (2011) Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men. J Nutr 141, 1286-1291.
42. Pfeuffer M, Fielitz K, Laue C, et al. (2011) CLA does not impair endothelial function and decreases body weight as compared with safflower oil in overweight and obese male subjects. J Am Coll Nutr 30, 19-28.
43. Smit LA, Baylin A & Campos H (2010) Conjugated linoleic acid in adipose tissue and risk of myocardial infarction. Am J Clin Nutr 92, 34-40.
44. Castro-Webb N, Ruiz-Narvaez EA & Campos H (2012) Cross-sectional study of conjugated linoleic acid in adipose tissue and risk of diabetes. Am J Clin Nutr 96, 175-181.
45. Venkatramanan S, Joseph SV, Chouinard PY, et al. (2010) Milk enriched with conjugated linoleic acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals. J Am Coll Nutr 29, 152-159.
46. Brown AW, Trenkle AH & Beitz DC (2011) Diets high in conjugated linoleic acid from pasture-fed cattle did not alter markers of health in young women. Nutr Res 31, 33-41.
47. Lacroix E, Charest A, Cyr A, et al. (2012) Randomized controlled study of the effect of a butter naturally enriched in trans fatty acids on blood lipids in healthy women. Am J Clin Nutr 95, 318-325.
48. Zlatanos SN, Laskaridis K & Sagredos A (2008) Conjugated linoleic acid content of human plasma. Lipids Health Dis 7, 34.
49. Sato K, Shinohara N, Honma T, et al. (2011) The change in conjugated linoleic acid concentration in blood of Japanese fed a conjugated linoleic acid diet. J Nutr Sci Vitaminol (Tokyo) 57, 364-371.
50. Declercq V, Taylor CG & Zahradka P (2011) Isomer-specific effects of conjugated linoleic acid on blood pressure, adipocyte size and function. Br J Nutr 107, 1413-1421.
51. Park Y, Terk M & Park Y (2011) Interaction between dietary conjugated linoleic acid and calcium supplementation affecting bone and fat mass. J Bone Miner Metab 29, 268-278.
52. Lasa A, Simon E, Churruca I, et al. (2011) Effects of trans-10, cis-12 CLA on liver size and fatty acid oxidation under-energy restriction conditions in hamsters. Nutrition 27, 116-121.
53. Obsen T, Faergeman NJ, Chung S, et al. (2012) Trans-10, cis-12 conjugated linoleic acid decreases de novo lipid synthesis in human adipocytes. J Nutr Biochem 23, 580-590.
54. Lasa A, Miranda J, Churruca I, et al. (2011) The combination of resveratrol and CLA does not increase the delipidating effect of each molecule in 3T3-L1 adipocytes. Nutr Hosp 26, 997-1003.
55. Ashwell MS, Ceddia RP, House RL, et al. (2010) Trans-10, cis-12-conjugated linoleic acid alters hepatic gene expression in a polygenic obese line of mice displaying hepatic lipidosis. J Nutr Biochem 21, 848-855.
56. Yu J, Yu B, Jiang H, et al. (2012) Conjugated linoleic acid induces hepatic expression of fibroblast growth factor 21 through PPAR-alpha. Br J Nutr 107, 461-465.
57. Hommelberg PP, Plat J, Remels AH, et al. (2010) Trans-10, cis-12 conjugated linoleic acid inhibits skeletal muscle differentiation and GLUT4 expression independently from NF-kappaB activation. Mol Nutr Food Res 54, 1763-1772.
58. Jiang S, Chen H, Wang Z, et al. (2011) Activated AMPK and prostaglandins are involved in the response to conjugated linoleic acid and are sufficient to cause lipid reductions in adipocytes. J Nutr Biochem 22, 656-664.
59. Martinez K, Kennedy A & McIntosh MK (2011) JNK inhibition by SP600125 attenuates trans-10, cis-12 conjugated linoleic acid-mediated regulation of inflammatory and lipogenic gene expression. Lipids 46, 885-892.
60. Zhai JJ, Liu ZL, Li JM, et al. (2010) Different mechanisms of cis-9, trans-11- and trans-10, cis-12- conjugated linoleic acid affecting lipid metabolism in 3T3-L1 cells. J Nutr Biochem 21, 1099-1105.
61. Stringer DM, Zahradka P, Declercq VC, et al. (2010) Modulation of lipid droplet size and lipid droplet proteins by trans-10, cis-12 conjugated linoleic acid parallels improvements in hepatic steatosis in obese, insulin-resistant rats. Biochim Biophys Acta 1801, 1375-1385.
62. DeClercq V, Zahradka P & Taylor CG (2010) Dietary t10, c12-CLA but not c9, t11 CLA reduces adipocyte size in the absence of changes in the adipose renin-angiotensin system in fa/fa Zucker rats. Lipids 45, 1025-1033.
63. Stachowska E, Siennicka A, Baskiewcz-Halasa M, et al. (2012) Conjugated linoleic acid isomers may diminish human macrophages adhesion to endothelial surface. Int J Food Sci Nutr 63, 30-35.
64. Rungapamestry V, McMonagle J, Reynolds C, et al. (2012) Inter-organ proteomic analysis reveals insights into the molecular mechanisms underlying the anti-diabetic effects of cis-9, trans-11-conjugated linoleic acid in ob/ob mice. Proteomics 12, 461-476.
65. Hsu YC, Meng X, Ou L, et al. (2010) Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells. Cell Signal 22, 590-599.
66. Stachowska E, Kijowski J, Dziedziejko V, et al. (2011) Conjugated linoleic acid regulates phosphorylation of PPAR-gamma by modulation of ERK 1/2 and p38 signaling in human macrophages/fatty acid-laden macrophages. J Agric Food Chem 59, 11846-11852.
67. Declercq V, Taylor CG, Wigle J, et al. (2012) Conjugated linoleic acid improves blood pressure by increasing adiponectin and endothelial nitric oxide synthase activity. J Nutr Biochem 23, 487-493.
68. Kim DI, Kim KH, Kang JH, et al. (2011) Trans-10, cis-12-conjugated linoleic acid modulates NF-kappaB activation and TNF-alpha production in porcine peripheral blood mononuclear cells via a PPARgamma-dependent pathway. Br J Nutr 105, 1329-1336.
69. Kim KH, Kim DI, Kim SH, et al. (2011) Trans-10, cis-12-conjugated linoleic acid attenuates tumor necrosis factor-alpha production by lipopolysaccharide-stimulated porcine peripheral blood mononuclear cells through induction of interleukin-10. Cytokine 56, 224-230.
70. Perdomo MC, Santos JE & Badinga L (2011) Trans-10, cis-12 conjugated linoleic acid and the PPAR-gamma agonist rosiglitazone attenuate lipopolysaccharide-induced TNF-alpha production by bovine immune cells. Domest Anim Endocrinol 41, 118-125.
71. Paek J, Kang JH, Kim SS, et al. (2010) Trans-10, cis-12 conjugated linoleic acid directly enhances the chemotactic activity of porcine peripheral blood polymorphonuclear neutrophilic leukocytes by activating F-actin polymerization in vitro. Res Vet Sci 89, 191-195.
72. Kelley NS, Hubbard NE & Erickson KL (2007) Conjugated linoleic acid isomers and cancer. J Nutr 137, 2599-2607.
73. Bialek A, Tokarz A, Dudek A, et al. (2010) Influence of diet enriched with conjugated linoleic acids on their distribution in tissues of rats with DMBA induced tumors. Lipids Health Dis 9, 126.
74. Bougnoux P, Hajjaji N, Maheo K, et al. (2010) Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Res 49, 76-86.
75. Heinze VM & Actis AB (2012) Dietary conjugated linoleic acid and long-chain n-3 fatty acids in mammary and prostate cancer protection: a review. Int J Food Sci Nutr 63, 66-78.
76. Hsu YC & Ip MM (2011) Conjugated linoleic acid-induced apoptosis in mouse mammary tumor cells is mediated by both G protein coupled receptor-dependent activation of the AMP-activated protein kinase pathway and by oxidative stress. Cell Signal 23, 2013-2020.
77. Rakib MA, Kim YS, Jang WJ, et al. (2010) Attenuation of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced gap junctional intercellular communication (GJIC) inhibition in MCF-10A cells by c9, t11-conjugated linoleic acid. J Agric Food Chem 58, 12022-12030.
78. Palmieri G, Bergamo P, Luini A, et al. (2011) Acylpeptide hydrolase inhibition as targeted strategy to induce proteasomal down-regulation. PloS one 6, e25888.
79. Degen C, Lochner A, Keller S, et al. (2011) Influence of in vitro supplementation with lipids from conventional and Alpine milk on fatty acid distribution and cell growth of HT-29 cells. Lipids Health Dis 10, 131.
80. Bassaganya-Riera J & Hontecillas R (2010) Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 13, 569-573.
81. Gorissen L, Raes K, Weckx S, et al. (2010) Production of conjugated linoleic acid and conjugated linolenic acid isomers by Bifidobacterium species. Appl Microbiol Biotechnol 87, 2257-2266.
82. Martin CA, Milinsk MC, Visentainer JV, et al. (2007) Trans fatty acid-forming processes in foods: a review. An Acad Bras Cienc 79, 343-350.
83. Kemeny Z, Recseg K, Henon G, et al. (2001) Deodorization of vegetable oils: prediction of trans polyunsaturated fatty acid content. J Am Oil Chem Soc 78, 973-979.
84. Mozaffarian D (2008) Commentary: ruminant trans fatty acids and coronary heart disease - cause for concern? Int J Epidemiol 37, 182-184.
85. Santora JE, Palmquist DL & Roehrig KL (2000) Trans-vaccenic acid is desaturated to conjugated linoleic acid in mice. J Nutr 130, 208-215.
86. Turpeinen AM, Mutanen M, Aro A, et al. (2002) Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76, 504-510.
87. Bhattacharya A, Banu J, Rahman M, et al. (2006) Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 17, 789-810.
88. Wolff RL, Combe NA, Destaillats F, et al. (2000) Follow-up of the delta4 to delta16 trans-18 : 1 isomer profile and content in French processed foods containing partially hydrogenated vegetable oils during the period 1995-1999. Analytical and nutritional implications. Lipids 35, 815-825.
89. Micha R, King IB, Lemaitre RN, et al. (2010) Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr 91, 883-893.
90. Sartika RA (2011) Effect of trans fatty acids intake on blood lipid profile of workers in East Kalimantan, Indonesia. Malays J Nutr 17, 119-127.
91. Varraso R, Kabrhel C, Goldhaber SZ, et al. (2012) Prospective study of diet and venous thromboembolism in US women and men. Am J Epidemiol 175, 114-126.
92. Vesper HW, Kuiper HC, Mirel LB, et al. (2012) Levels of plasma trans-fatty acids in non-Hispanic white adults in the United States in 2000 and 2009. JAMA 307, 562-563.
93. Laake I, Pedersen JI, Selmer R, et al. (2011) A prospective study of intake of trans-fatty acids from ruminant fat, partially hydrogenated vegetable oils, and marine oils and mortality from CVD. Br J Nutr 108, 743-754.
94. Hansen CP, Berentzen TL, Halkjaer J, et al. (2012) Intake of ruminant trans fatty acids and changes in body weight and waist circumference. Eur J Clin Nutr 66, 1104-1109.
95. Baylin A, Kabagambe EK, Ascherio A, et al. (2003) High 18 : 2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in Costa Rican adults. J Nutr 133, 1186-1191.
96. Lemaitre RN, King IB, Mozaffarian D, et al. (2006) Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: The Cardiovascular Health Study. Circulation 114, 209-215.
97. Kraft J, Spiltoir JI, Salter AM, et al. (2011) Differential effects of the trans-18 : 1 isomer profile of partially hydrogenated vegetable oils on cholesterol and lipoprotein metabolism in male F1B hamsters. J Nutr 141, 1819-1826.
98. Teixeira AM, Dias VT, Pase CS, et al. (2012) Could dietary trans fatty acids induce movement disorders? Effects of exercise and its influence on NaK-ATPase and catalase activity in rat striatum. Behav Brain Res 226, 504-510.
99. Collison KS, Zaidi MZ, Saleh SM, et al. (2012) Nutrigenomics of hepatic steatosis in a feline model: effect of monosodium glutamate, fructose, and trans-fat feeding. Genes Nutr 7, 265-280.
100. Dhibi M, Brahmi F, Mnari A, et al. (2011) The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats. Nutr Metab 8, 65.
101. Pimentel GD, Lira FS, Rosa JC, et al. (2012) Intake of trans fatty acids during gestation and lactation leads to hypothalamic inflammation via TLR4/NFkappaBp65 signaling in adult offspring. J Nutr Biochem 23, 265-271.
102. Bowman GL, Silbert LC, Howieson D, et al. (2012) Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 78, 241-249.
103. Harvey KA, Arnold T, Rasool T, et al. (2008) Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 99, 723-731.
104. Kummerow FA, Zhou Q & Mahfouz MM (1999) Effect of trans fatty acids on calcium influx into human arterial endothelial cells. Am J Clin Nutr 70, 832-838.
105. Iwata NG, Pham M, Rizzo NO, et al. (2011) Trans fatty acids induce vascular inflammation and reduce vascular nitric oxide production in endothelial cells. PloS one 6, e29600.
106. Mozaffarian D (2006) Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler Suppl 7, 29-32.
107. Fournier N, Attia N, Rousseau-Ralliard D, et al. (2012) Deleterious impact of elaidic fatty acid on ABCA1-mediated cholesterol efflux from mouse and human macrophages. Biochim Biophys Acta 1821, 303-312.
108. Enke U, Jaudszus A, Schleussner E, et al. (2011) Fatty acid distribution of cord and maternal blood in human pregnancy: special focus on individual trans fatty acids and conjugated linoleic acids. Lipids Health Dis 10, 247.
109. Rosenthal MD & Doloresco MA (1984) The effects of trans fatty acids on fatty acyl delta 5 desaturation by human skin fibroblasts. Lipids 19, 869-874.
110. Tyburczy C, Major C, Lock AL, et al. (2009) Individual trans octadecenoic acids and partially hydrogenated vegetable oil differentially affect hepatic lipid and lipoprotein metabolism in golden Syrian hamsters. J Nutr 139, 257-263.
111. Wang Y, Jacome-Sosa MM, Ruth MR, et al. (2009) Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats. J Nutr 139, 2049-2054.
112. Bassett CM, Edel AL, Patenaude AF, et al. (2010) Dietary vaccenic acid has antiatherogenic effects in LDLr-/- mice. J Nutr 140, 18-24.
113. Jacome-Sosa MM, Lu J, Wang Y, et al. (2010) Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat. Nutr Metab 7, 60.
114. Anadon A, Martinez-Larranaga MR, Martinez MA, et al. (2011) A 4-week repeated oral dose toxicity study of dairy fat naturally enriched in vaccenic, rumenic and alpha-linolenic acids in rats. J Agric Food Chem 59, 8036-8046.
115. Sun X, Zhang J, Macgibbon AK, et al. (2011) Bovine milk fat enriched in conjugated linoleic and vaccenic acids attenuates allergic dermatitis in mice. Clin Exp Allergy 41, 729-738.
116. Van Nieuwenhove CP, Cano PG, Perez-Chaia AB, et al. (2011) Effect of functional buffalo cheese on fatty acid profile and oxidative status of liver and intestine of mice. J Med Food 14, 420-427.
117. Wang Y, Jacome-Sosa MM, Ruth MR, et al. (2012) The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-α and -γ in a rodent model of dyslipidemia and the metabolic syndrome. Mol Nutr Food Res 56, 1234-1246.
118. Chardigny JM, Destaillats F, Malpuech-Brugere C, et al. (2008) Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 87, 558-566.
119. Motard-Belanger A, Charest A, Grenier G, et al. (2008) Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 87, 593-599.
120. Tardy AL, Lambert-Porcheron S, Malpuech-Brugere C, et al. (2009) Dairy and industrial sources of trans fat do not impair peripheral insulin sensitivity in overweight women. Am J Clin Nutr 90, 88-94.
121. Onakpoya IJ, Posadzki PP, Watson LK, et al. (2012) The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials. Eur J Nutr 51, 127-134.
122. Schoeller DA, Watras AC & Whigham LD (2009) A meta-analysis of the effects of conjugated linoleic acid on fat-free mass in humans. Appl Physiol Nutr Metab 34, 975-978.
123. Whigham LD, Watras AC & Schoeller DA (2007) Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr 85, 1203-1211.
124. Lenz TL & Hamilton WR (2004) Supplemental products used for weight loss. J Am Pharm Assoc 44, 59-67, quiz 67-58.
125. Salas-Salvadó J, Marquez-Sandoval F & Bullo M (2006) Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr 46, 479-488.
126. Tricon S & Yaqoob P (2006) Conjugated linoleic acid and human health: a critical evaluation of the evidence. Curr Opin Clin Nutr Metab Care 9, 105-110.
127. Bachmair EM, Bots ML, Mennen LI, et al. (2012) Effect of supplementation with an 80:20 cis9, trans11 conjugated linoleic acid blend on the human platelet proteome. Mol Nutr Food Res 56, 1148-1159.
128. Labonte ME, Couture P, Paquin P, et al. (2011) Comparison of the impact of trans fatty acids from ruminant and industrial sources on surrogate markers of cholesterol homeostasis in healthy men. Mol Nutr Food Res 55, Suppl. 2, S241-S247.